Breast Carcinoma Amplified Sequence 2 (BCAS2) Polyclonal Antibody
The Breast Carcinoma Amplified Sequence 2 (BCAS2) Polyclonal Antibody is applicable for the following applications: WB, IHC, ICC, IP. Host: Rabbit. Species Reactivity: Human (Homo sapiens) . Immunogen: Ala2~Phe225. Accession Number: O75934. Gene ID: 10286. Target Synonyms: DAM1; SPF27; Pre-mRNA-Splicing Factor SPF27; DNA amplified in mammary carcinoma 1 protein; Spliceosome-associated protein SPF 27. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
Short Description
The Breast Carcinoma Amplified Sequence 2 (BCAS2) Polyclonal Antibody is applicable for the following applications: WB, IHC, ICC, IP.
Gene ID
10286
Accession Number
O75934
Host
Rabbit
Reactivity
Human (Homo sapiens)
Immunogen
Ala2~Phe225
Target
Breast Carcinoma Amplified Sequence 2 (BCAS2)
Clonality
Polyclonal
Conjugation
Applications
WB, IHC, ICC, IP
Field of Research
Tumor Immunity
Purification
Protein A + Protein G affinity chromatography
Concentration
0.5mg/ml
Buffer
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol
Shipping Conditions
Ice packs
Storage Conditions
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Appearance
Liquid
Target Alternative Name
DAM1; SPF27; Pre-mRNA-Splicing Factor SPF27; DNA amplified in mammary carcinoma 1 protein; Spliceosome-associated protein SPF 27
Species
Human (Homo sapiens)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD16 (C16/1045), CF405S conjugate, 0.1mg/mL
Complement C4d (C4D204), CF594 conjugate, 0.1mg/mL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF640R conjugate, 0.1mg/mL
